Bryan Mazlish

Bigfoot Biomedical, Inc. operates as a health solution company. It focuses on optimizing the care of people with Type 1 Diabetes (T1D). The firm develops an automated insulin delivery solution for the management of T1D based on cloud connectivity and human-centered-automation. The company was founded by Jeffrey S. Brewer, Jon Brilliant, Bryan Mazlish and Lane Desborough in November 2014 and is headquartered in Milpitas, CA.

Chardan Nextech Acquisition Corp. operates as a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on June 23, 2020 and is headquartered in New York, NY.

Surf Bio, Inc. is a preclinical biopharmaceutical company that develops enhanced therapeutic solutions for various therapeutic areas, including diabetes, oncology, infectious diseases, and gene therapy. The company is based in Palo Alto, CA, and was founded by Jennifer Schneider and Bryan Mazlish. The company leverages a novel biotechnology platform and a breakthrough drug stabilization technology developed in the Appel lab. The technology enables a reduction of refrigeration requirements, transition from IV to subcutaneous therapy, and novel pharmaceutical formulations. Surf Bio was launched by the founders of Bigfoot Biomedical and Mode AGC. Bryan Mazlish has been the CEO since incorporation.

PhysioLogic Devices, Inc. provides treatment for people with type 1 diabetes. It develops implantable intraperitoneal closed-loop artificial pancreas which eliminates the need for testing blood sugars and taking insulin through the skin. The company was founded by Peter Lord and is headquartered in Alpine, CA.